Enhanced AC133-Specific CAR T Cell Therapy Induces Durable Remissions in Mice with Metastatic Small Cell Lung Cancer

Scientists studied the effectiveness of AC133-specific CAR T cells post-chemotherapy using human primary small cell lung cancer and an orthotopic xenograft mouse model.